Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Mayo Clinic
Mayo Clinic
BerGenBio ASA
Sumitomo Pharma America, Inc.
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
Celgene
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Indiana University
Indiana University
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey